Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1986-11-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-0147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16 Suppl 3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3770548-Adult,
pubmed-meshheading:3770548-Aged,
pubmed-meshheading:3770548-Aged, 80 and over,
pubmed-meshheading:3770548-Arterial Occlusive Diseases,
pubmed-meshheading:3770548-Catheterization,
pubmed-meshheading:3770548-Fibrinolytic Agents,
pubmed-meshheading:3770548-Humans,
pubmed-meshheading:3770548-Infusions, Intra-Arterial,
pubmed-meshheading:3770548-Middle Aged
|
pubmed:year |
1986
|
pubmed:articleTitle |
Thrombolytic treatment in obliterative arterial disease. Can thrombolytic agents compete with surgery?
|
pubmed:publicationType |
Journal Article
|